Advertisement

Chronische Hepatitis C, HCV-Virämie und HCV-Genotyp bei HIV-seropositiven und HIV-seronegativen Hämophilen

  • M. von Depka Prondzinski
  • A. Berger
  • I. Scharrer
  • B. Weber
Conference paper

Zusammenfassung

Unter Blut- und Blutproduktempfängern muß von einer hohen Prävalenz an HCV-Antikörper ausgegangen werden. Dies gilt insbesondere bei Vorliegen einer chronisch viralen Hepatitis [1–12]. Man nimmt an, daß ein hoher Prozentsatz aller Patienten mit nachweisbaren Antikörpern gegen HCV an einer chronischen Hepatitis und infolge dessen an einer Leberzirrhose erkranken [13–16]. Auch das hepatozelluläre Karzinom scheint bei HCV-seropositiven Patienten häufiger vorzukommen [17 – 22].

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Grob PJ, Joller Jemelka HJ (1990) Hepatitis-C-Virus (HCV), Anit-HCV und Non-A-Non-B Hepatitis. Schweiz Med Wochenschr 120:117–124PubMedGoogle Scholar
  2. 2.
    Roggendorf M, Deinhardt F, Rasshofer R, Eberle J, Hopf U, Möller B, Zachoval R, Pape G, Schramm W, Rommel F (1989) Antibodies to hepatitis C virus (anti-HCV). Lancet 2:324 – 325PubMedCrossRefGoogle Scholar
  3. 3.
    Esteban JI, Gonzales A, Hernandez JM et al. (1990) Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis. N Engl J Med 323:1107 – 1112PubMedCrossRefGoogle Scholar
  4. 4.
    Ludlam CA, Chapman D, Cohen BJ, Litton PA (1989) Antibodies to hepatitis C virus in haemophilia. Lancet 2:560Google Scholar
  5. 5.
    Hatzakis A, Polychronaki H, Miriagou V et al. (1992) Antibody responses to hepatitis C virus by second-generation immunoassays in a cohort of patients with bleeding disorders. Vox Sang 63:204 – 209PubMedCrossRefGoogle Scholar
  6. 6.
    Pistello M, Ceccherini-Nelli L, Cecconi N et al. (1991) Hepatitis C virus seroprevalence in Italian haemophiliacs injected with virus-inactivated concentrates: five year follow-up and correlation with antibodies to other viruses. J Med Virol 33:43 – 46PubMedCrossRefGoogle Scholar
  7. 7.
    Watson HG, Ludlam CA, Rebus S, Zhang LQ, Peutherer JF, Simmonds P (1992) Use of several second generation serological assays to determine the true prevalence of hepatitis C virus infection in haemophiliacs treated with non-virus inactivated factor VIII and IX concentrates. Br J Haematol 80:514–518PubMedCrossRefGoogle Scholar
  8. 8.
    Maisonneuve P, Laurian Y, Guerois C, Verroust F, Ferrer Le Coeur F, Courouce AM, Noel L (1991) Antibody to hepatitis C (anti C 100–3) in French hemophiliacs. Nouv Rev Fr Hematol 33:263–266PubMedGoogle Scholar
  9. 9.
    Brettler DB, Alter HJ, Dienstag JL, Forsberg AD, Levine PH (1990) Prevalence of hepatitis C virus antibody in a cohort of hemophilia patients. Blood 76:254 – 256PubMedGoogle Scholar
  10. 10.
    Polywka S, Laufs R (1991) Hepatitis C virus antibodies among different groups at risk and patients with suspected non-A, non-B hepatitis. Infektion 19:81 – 84CrossRefGoogle Scholar
  11. 11.
    Esteban JI, Esteban R, Viladomiu L, Lopez-Talavera JC, Gonzalez A, Hernandez JM, Roget M, Vargas V, Genesca J, Buti M et al. (1989) Hepatitis C virus antibodies among risk groups in Spain. Lancet 2:294 – 297PubMedCrossRefGoogle Scholar
  12. 12.
    Van der Poel CL, Reesink HW, Lelie PN, Leentvar-Kuypers A, Choo QL, Kuo G (1989) Antihepatitis C antibodies and Non-A, Non-B post-transfusion hepatitis in the Netherlands. Lancet 2:297–298PubMedGoogle Scholar
  13. 13.
    Sansonno D, Dammacco F (1989) Antibodies to hepatitis C virus in Non-A, Non-B post-transfusion and cryptogenetic chronic liver disease. Lancet 2:798 – 799PubMedCrossRefGoogle Scholar
  14. 14.
    Makris M, Preston FE, Triger DR, Underwood JC, Choo QL, Kuo G, Houghton M (1990) Hepatitis C antibody and chronic liver disease in haemophilia. Lancet 335:1117–1119PubMedCrossRefGoogle Scholar
  15. 15.
    Hay CRM, Preston FE, Triger DR, Underwood JCE (1985) Progressive liver disease in haemophilia: an understated problem? Lancet 1:1495–1497PubMedCrossRefGoogle Scholar
  16. 16.
    Dienstag JL (1983) Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features. Gastroenterology 85:439 – 462PubMedGoogle Scholar
  17. 17.
    Simonetti RG, Cottone M, Craxi A, Pagliaro L, Rapicetta M, Chionne P, Costantino A (1989) Prevalence of antibodies to hepatitis C virus in hepatocellular carcinoma. Lancet 2:1338PubMedCrossRefGoogle Scholar
  18. 18.
    Colombo M, Kuo G, Choo QL, Donato MF, Del Ninno E, Tommasini MA, Dioguardi N et al. (1989) Prevalence of antibodies to hepatitis C virus in Italien patients with hepatocellular carcinoma. Lancet 2:1006 – 1008PubMedCrossRefGoogle Scholar
  19. 19.
    Bruix J, Barrera JM, Calvet X, Ercilla G, Costa J, Sanchez-Tapias JM, Ventura M, Bru C, Castillo R, Rodes J (1989) Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet 2:1004–1006PubMedCrossRefGoogle Scholar
  20. 20.
    Yu MC, Tong MJ, Coursaget P (1990) Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States. J Natl Cancer Inst 82:1038–1041PubMedCrossRefGoogle Scholar
  21. 21.
    Chiaramonte M et al. (1990) Antibody to hepatitis in hepatocellular carcinoma. Lancet 335:301–302Google Scholar
  22. 22.
    Noel L, Guerois C, Maisonneuve P, Verroust F, Laurian Y (1989) Antibodies to hepatitis C virus in haemophilia. Lancet 2:560CrossRefGoogle Scholar
  23. 23.
    Eyster ME, Diamondstone LS, Lien JM, Ehmann WC, Quan S, Goedert JJ (1993) Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effect of coinfection with human immunodeficiency virus. J Acquir Immune Defic Syndr 6:602 – 610PubMedGoogle Scholar
  24. 24.
    Martin P, Di Bisceglie AM, Kassianides C, Lisker-Melman M et al. (1989) Rapidly progressive non-A, non-B hepatitis in patients with human immunodeficiency virus infection. Gastroenterology 97:1559 – 1561PubMedGoogle Scholar
  25. 25.
    Eyster ME, Fried MW, Di Bisceglie AM, Goedert JJ (1994) Increasing hepatitis C virus RNA levels in hemophiliacs: relationship to human immunodeficiency virus infection and liver disease. Multicenter Hemophilia Cohort Study. Blood 84:1020–1023PubMedGoogle Scholar
  26. 26.
    Troisi CL, Hollinger FB, Hoots WK, Contant C, Gill J, Ragni M, Parmley R, Sexauer C, Gomperts E et al. (1993) A multicenter study of viral hepatitis in a United States hemophilic population. Blood 81:412 – 418PubMedGoogle Scholar
  27. 27.
    Eyster ME, Diamondstone LS, Goedert JJ (1992) Hepatic AIDS in persons with hemophilia coinfected with hepatitis C virus (HCV) and human immunodeficiency virus (HIV). The Multicenter Hemophilia Cohort Study. Int Conf AIDS 1992 Juli 19–24 8: B164Google Scholar
  28. 28.
    Schulman S, Grillner L (1990) Antibodies against hepatitis C in a population of Swedish haemophiliacs and heterosexual partners. Scand J Infect Dis 22:393–397PubMedCrossRefGoogle Scholar
  29. 29.
    Watson HG, Zhang LQ, Simmonds P, Ludlam CA (1992) Hepatitis C virus load increases with time after HIV infection. Int Conf AIDS 1992 July 19 – 24 8: B195Google Scholar
  30. 30.
    Yoshioka K, Kakumu S, Wakita T, Ishikawa T, Itoh Y, Takayanagi M, Higashi Y, Shibata M, Morishima T (1992) Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus. Hepatology 16:293 – 299PubMedCrossRefGoogle Scholar
  31. 31.
    McOmish F, Chan SW, Dow DB, Gillon J, Frame WD, Crawford RJ, Yap PL et al. (1993) Detection of three hepatitis C virus in blood donors: investigation of type-specific differences in serologic reactivity and rate of alanine transferase abnormalities. Transfusion 33:7–13PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1996

Authors and Affiliations

  • M. von Depka Prondzinski
  • A. Berger
  • I. Scharrer
  • B. Weber

There are no affiliations available

Personalised recommendations